Home arrow Publication Series arrow PharmaVitae arrow PharmaVitae 2005: Genzyme Global Analysis
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Publication Series arrow PharmaVitae arrow PharmaVitae 2005: Genzyme Global Analysis

PharmaVitae 2005: Genzyme Global Analysis


Price: $3 800.00


Introduction

This analysis examines the current position and future outlook for Genzyme in the biotechnology sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

  • Benchmark Genzyme’s performance against key rivals in the biotechnology sector
  • Understand the impact of Genzyme’s M&A strategy

Pages: 90

Table of Contents

Download TOC in PDF


PharmaVitae Reports

View all available PharmaVitae Reports




:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















Featured Products


Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group